# Nuclide record caix-pet (technology). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/technologies/caix-pet/>
  a schema:MedicalTherapy ;
  nuclide:kind "technology" ;
  schema:identifier "caix-pet" ;
  schema:name "CAIX PET (89Zr-girentuximab)"@en ;
  schema:description "CAIX PET is a scan using an antibody against a protein almost unique to clear-cell kidney cancer, to tell cancer from benign kidney lumps without a biopsy."@en ;
  schema:url <https://nuclide.cc/technologies/caix-pet/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(24)00402-9> ;
  nuclide:status "phase-3" ;
  nuclide:related <https://nuclide.cc/isotopes/zr-89/>, <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/rcc/> ;
  nuclide:technologies <https://nuclide.cc/technologies/immuno-pet/>, <https://nuclide.cc/technologies/pet/> ;
  nuclide:companies <https://nuclide.cc/companies/telix/> ;
  nuclide:pathways <https://nuclide.cc/pathways/hif-vhl/> .